|
🐜
|
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
15 auth.
S. Tsimikas,
E. Karwatowska-Prokopczuk,
I. Gouni-Berthold,
J. Tardif,
S. Baum,
E. Steinhagen-Thiessen,
M. Shapiro,
E. Stroes,
P. Moriarty,
B. Nordestgaard,
...
S. Xia,
J. Guerriero,
N. Viney,
L. O’Dea,
J. Witztum
|
9 |
2020 |
9
🐜
|
|
🐜
|
Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
8 auth.
B. Leder,
L. O’Dea,
J. Zanchetta,
Prasana Kumar,
K. Banks,
Kate Mckay,
...
C. Lyttle,
G. Hattersley
|
7 |
2015 |
7
🐜
|
|
🐢
|
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
13 auth.
D. Gaudet,
E. Karwatowska-Prokopczuk,
S. Baum,
E. Hurh,
Joyce Kingsbury,
Victoria J Bartlett,
Amparo L. Figueroa,
P. Piscitelli,
W. Singleton,
J. Witztum,
...
R. Geary,
S. Tsimikas,
L. O’Dea
|
7 |
2020 |
7
🐢
|
|
🐬
|
Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone.
D. Spratt,
L. O’Dea,
D. Schoenfeld,
J. Butler,
P. Rao,
W. Crowley
|
7 |
1988 |
7
🐬
|
|
🐜
|
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
8 auth.
V. Alexander,
S. Xia,
E. Hurh,
S. Hughes,
L. O’Dea,
R. Geary,
...
J. Witztum,
S. Tsimikas
|
7 |
2019 |
7
🐜
|
|
🐜
|
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
13 auth.
I. Gouni-Berthold,
V. Alexander,
Qingqing Yang,
E. Hurh,
E. Steinhagen-Thiessen,
P. Moriarty,
S. Hughes,
D. Gaudet,
R. Hegele,
L. O’Dea,
...
E. Stroes,
S. Tsimikas,
J. Witztum
|
6 |
2021 |
6
🐜
|
|
🐬
|
Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
J. Finkelstein,
R. Whitcomb,
L. O’Dea,
C. Longcope,
D. Schoenfeld,
W. Crowley
|
6 |
1991 |
6
🐬
|
|
🐢
|
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer.
7 auth.
P. L. Chang,
S. Kenley,
T. Burns,
G. Denton,
K. Currie,
G. Devane,
...
L. O’Dea
|
6 |
2001 |
6
🐢
|
|
🐢
|
Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome
E. Loumaye,
P. Engrand,
C. Howles,
L. O’Dea
|
6 |
1997 |
6
🐢
|
|
🐢
|
Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism.
9 auth.
A. Matsumoto,
P. Snyder,
S. Bhasin,
K. Martin,
T. Weber,
S. Winters,
...
D. Spratt,
J. Brentzel,
L. O’Dea
|
5 |
2009 |
5
🐢
|
